Renaissance Technologies - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$7,783
-52.5%
1,692,053
-33.3%
0.01%
-45.8%
Q2 2023$16,386
-22.7%
2,536,603
-9.8%
0.02%
-14.3%
Q1 2023$21,199
-1.4%
2,811,503
+32.5%
0.03%
-3.4%
Q4 2022$21,500
-99.9%
2,122,403
-28.8%
0.03%
-31.0%
Q3 2022$29,480,000
-31.4%
2,980,803
-26.2%
0.04%
-17.6%
Q2 2022$42,987,000
+68.4%
4,036,303
+54.2%
0.05%
+70.0%
Q1 2022$25,522,000
+231.0%
2,617,603
+385.5%
0.03%
+200.0%
Q4 2021$7,711,000
+356.5%
539,203
+539.6%
0.01%
+400.0%
Q3 2021$1,689,000
-81.0%
84,300
-79.1%
0.00%
-81.8%
Q2 2021$8,870,000403,2000.01%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DCVC Bio GP, LLC 29,411$313,000100.00%
Founders Fund VII Management, LLC 3,773,530$40,188,00093.02%
Gruss & Co., LLC 363,778$3,874,00026.99%
Founders Fund Growth Management, LLC 407,017$4,334,00012.66%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$44,387,0005.09%
HARVARD MANAGEMENT CO INC 4,105,095$43,719,0005.06%
Intellectus Partners, LLC 1,089,755$11,606,0003.99%
ArchPoint Investors 630,326$6,713,0002.66%
BRANDYWINE MANAGERS, LLC 56,976$607,0001.49%
Orbimed Advisors 4,180,768$44,525,0000.81%
View complete list of ABCELLERA BIOLOGICS INC shareholders